Alnylam Pharmaceuticals I... (ALNY)
Alnylam Pharmaceuticals Max Pain By Strike
ALNY trades at $449.02, 32.1% above the near-term max pain of $340 expiring Sep 19, 2025 (33 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($230-$400), signaling increased put positioning or downside protection. Key magnetic zone at 290 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Alnylam Pharmaceuticals Max Pain By Expiry
Max pain for ALNY shows a downward trend from 400 to 230, indicating bearish sentiment or hedging activity. The 52% spread signals divergent expectations across timeframes. Most levels below 449.02 may cap rallies. Strong magnetic level at 290 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Sep 19, 2025 | 340 | -109.02 (-24.28%) |
Oct 17, 2025 | 390 | -59.02 (-13.14%) |
Dec 19, 2025 | 290 | -159.02 (-35.41%) |
Jan 16, 2026 | 290 | -159.02 (-35.41%) |
Mar 20, 2026 | 400 | -49.02 (-10.92%) |
Jun 18, 2026 | 400 | -49.02 (-10.92%) |
Jul 17, 2026 | 290 | -159.02 (-35.41%) |
Jan 15, 2027 | 230 | -219.02 (-48.78%) |